About the Company
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Fort Worth, Texas. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OMCL News
Omnicell Announces XT Amplify
Omnicell Announces XT Amplify: Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated ...
Commit To Buy Omnicell At $15, Earn 5.6% Annualized Using Options
Investors eyeing a purchase of Omnicell Inc (Symbol: OMCL) stock, but tentative about paying the going market price of $27.53/share, might benefit from considering selling puts among the ...
Reasons for the Decline of Omnicell (OMCL)
Brown Capital Management Mid Company Fund featured stocks like Omnicell, Inc. (NASDAQ:OMCL) in the Q4 2023 investor letter.
Omnicell, Inc. (OMCL)
As of the latest data, several digital health companies stand […] It's been a sad week for Omnicell, Inc. ( NASDAQ:OMCL ), who've watched their investment drop 14% to US$27.41 in the ...
Omnicell's (OMCL) Portfolio Expansion Aids Amid Macro Woes
Omnicell, Inc. price | Omnicell, Inc. Quote Earlier in 2023, a major southern health system customer expanded the service to nearly 20 hospitals across its health system for increased digitization ...
Omnicell launches XT Amplify to enhance dispensing system
FORT WORTH, Texas - Omnicell , Inc. (NASDAQ:OMCL), a company specializing in pharmacy care delivery models, today unveiled XT Amplify, an innovation program aimed at enriching the capabilities of ...
Investors in Omnicell (NASDAQ:OMCL) have unfortunately lost 80% over the last three years
Every investor on earth makes bad calls sometimes. But really big losses can really drag down an overall portfolio.
Omnicell Announces XT Amplify
Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a ...
Omnicell Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Omnicell, Inc. (OMCL)
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Loading the latest forecasts...